A goal of Healthy People 2010 is to increase the influenza immunization rate among high-risk populations to at least 90 percent. This article presents the results of a survey on influenza immunizations among African-Americans and Caucasian Medicare beneficiaries in a 25-county project intervention area in Texas. Information on the burden of suffering from pneumonia and influenza, the benefits of influenza immunization, and recommendations are included. Data are presented on the characteristics of the African-American and Caucasian Medicare beneficiary survey respondents, their influenza immunization rates, health status and sources of health care, and factors that influence them to obtain an annual influenza immunization.
Get full access to this article
View all access options for this article.
References
1.
American Hospital Association (1994). “Management Advisory— Health Care Delivery: Immunization.” Washington, D.C.: American Hospital Association Technical Panel on Infections within Hospitals, American Journal of Infectious Control22:42–46.
2.
BlocheM.G. (2001). “Clinical Loyalties and the Social Purpose of Medicine.” Yale Journal of Health Policy, Law, and Ethics1:95–131.
3.
Centers for Disease Control and Prevention (1993). “Final Results: Medicare Influenza Vaccine Demonstration—Selected States. 1988–1992.” MMWR Morbidity and Mortality Weekly Report42:601–604.
4.
Centers for Disease Control and Prevention (1995). “Pneumonia and Influenza Death Rates—United States, 1979–1994.” MMWR Morbidity and Mortality Weekly Report44:535–537.
5.
Centers for Disease Control and Prevention (1999). “Reasons Reported by Medicare Beneficiaries for not Receiving Influenza and Pneumoccoccal Vaccinations—United States, 1996.” MMWR Morbidity and Mortality Weekly Report48: 556–559.
6.
Centers for Disease Control and Prevention (2001). “Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunizations Practices (ACIP.” MMWR Morbidity and Mortality Weekly Report50:1–28.
7.
CollinsC.S., HallA., and NewhausC. (1999). U.S. Minority Health: A Charbook. New York: Commonwealth Fund.
8.
CouchR.B.. (1986). “Influenza: Its Control in Persons and Populations.” Journal of Infectious Diseases153:431–440.
9.
FedsonDavid. (1993). “Clinical Effectiveness of Influenza Vaccination in Manitoba.” Journal of the American Medical Association270:1956–1971.
10.
FlemingD.M.. (1995). “Study of the Effectiveness of Influenza Vaccination in the Elderly in the Epidemic of 1989–90 Using a General Practice Database.” Epidemiology Infections115:581–589.
11.
FosterDavid. (1992). “Influenza Vaccine Effectiveness in Preventing Hospitalization for Pneumonia in the Elderly.” American Journal of Epidemiology136:296–307.
12.
GrossPeter. (1995). “The Efficacy of Influenza Vaccine in Elderly Persons: A Meta-analysis and Review of the Literature.” Annals of Internal Medicine123:518–527.
HelliwellB.E. and DrumondM.E. (1988). “The Costs and Benefits of Prevention Influenza in Ontario's Elderly.” Canadian Journal of Public Health79:175–179.
15.
Institute of Medicine (2002). Unequal Treatment: Confronting Racial and Ethnic Disparities in Health Care. Washington, D.C.: National Academy Press.
16.
KatzJeffrey N. (2001). “Patient Preferences and Health Disparities.” Journal of the American Medical Association286:1506–1509.
17.
Lillie-BlantonM., MartinezR.M., and SalganicoffA. (2001). “Site of Medical Care: Do Racial and Ethnic Differences Persist?” Yale Journal of Health Policy, Law, and Ethics1(1):1–17.
18.
MaucherJ.M. and GambertS.R. (1990). “Cost-Effectiveness Analysis of Influenza Vaccination in the Elderly.” Age13:81–95.
19.
McInerneyM.J.. (1995). “Self-Reported Influenza Immunization Rates for Medicare Beneficiaries in Montana and Wyoming.” Journal of Clinical Outcomes Management8(5):31–35.
20.
MulloolyJohn P. (1994). “Influenza Vaccination Programs for Elderly Persons: Cost-effectiveness in a Health Maintenance Organization.” Annals of Internal Medicine121:947–952.
21.
NicholK.L.. (1996). “Effectiveness of Influenza Vaccine in the Elderly.” Gerontology42:274–279.
22.
OhmitSuzanne E. and MontoArnold S. (1995). “Influenza Vaccine Effectiveness in Preventing Hospitalization among the Elderly during Influenza Type A and Type B Seasons.” International Journal of Epidemiology24:1240–1248.
23.
SchneiderEric C.. (2001). “Racial Disparity in Influenza Vaccination: Does Managed Care Narrow the Gap Between African-Americans and Whites?” Journal of the American Medical Association286 (12):1455–1460.
24.
SheaS.. (1991). “Reliability of the Behavioral Risk Factor Survey in a Triethnic Population.” American Journal of Epidemiology133:489–500.
25.
SimonsenLone. (1997). “The Impact of Influenza Epidemics on Mortality: Introducing a Severity Index.” American Journal of Public Health87:1944–1850.
26.
SteinA.D.. (1995). “Reproducibility of Responses to Telephone Interviews: Demographic Predictors of Discordance in Risk Factor Status.” American Journal of Epidemiology141:1097–1105.
WilliamsWalter W.. (1988). “Immunization Policies and Vaccine Coverage among Adults: The Risk for Missed Opportunities.” Annals of Internal Medicine108:616–625.
